Omeros Cash Flow Statement
NASDAQ: OMERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
19.83+0.71 (+3.71%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Omeros free cash flow
In fiscal 2025, Omeros generated -$116.1 million of operating cash flow and spent $65,000 on capital expenditures. That left free cash flow of -$116.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
Omeros cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -3.35M | -156.81M | -117.81M | 47.42M | 194.24M | -138.06M | -84.49M | -126.76M | -53.48M | -66.75M |
| Net Income growth (YoY) | — | — | -348.46% | -75.59% | — | — | — | — | — | — |
| Depreciation & Amortization | 964.00K | 950.00K | 920.00K | 952.00K | 1.39M | 1.62M | 1.79M | 962.00K | 551.00K | 300.00K |
| Stock-Based Compensation | 8.19M | 10.49M | 11.65M | 14.07M | 17.63M | 14.93M | 13.79M | 11.71M | 12.69M | 13.58M |
| Change in Working Capital | 93.00K | -4.37M | 206.83M | -184.80M | -14.11M | 7.38M | -1.45M | 4.29M | -172.00K | -6.25M |
| Operating Cash Flow | -116.09M | -148.80M | 74.73M | -86.48M | -109.72M | -100.09M | -60.07M | -103.74M | -36.23M | -51.50M |
| Capital Expenditures | -65.00K | -165.00K | -426.00K | -113.00K | -277.00K | -283.00K | -334.00K | -567.00K | -350.00K | -126.00K |
| Investing Cash Flow | 164.52M | 82.22M | 27.45M | -127.56M | 193.71M | -67.03M | -3.40M | 25.15M | -37.60M | -16.34M |
| Share Repurchases | 0 | -11.85M | -4.65M | 0 | 0 | — | — | — | — | — |
| Debt Issued | — | — | — | — | — | 225.03M | — | 44.55M | 0 | 100.00M |
| Financing Cash Flow | -42.17M | 62.88M | -106.08M | 124.25M | 6.32M | 174.53M | 60.70M | 81.05M | 75.00M | 68.70M |
| Net Change in Cash | 6.26M | -3.71M | -3.90M | -89.80M | 90.31M | 7.42M | -2.78M | 2.47M | 1.17M | 859.00K |
| Free Cash Flow | -116.16M | -148.97M | 74.30M | -86.60M | -110.00M | -100.37M | -60.41M | -104.30M | -36.58M | -51.63M |
This table shows 10 annual periods of Omeros's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OMER's reporting calendar. What is a cash flow statement?